Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy

E-ISSN： 1873-4286|21|42|6104-6124

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.42, 2015-12, pp. : 6104-6124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solid Lipid Nanoparticles Containing Tamoxifen Characterization and In Vitro Antitumoral Activity

By Fontana Giacomo Maniscalco Laura Schillaci Domenico Cavallaro Gennara Giammona Gaetano

Drug Delivery, Vol. 12, Iss. 6, 2005-11 ,pp. : 385-392

Informa Healthcare

Access to resources Recommend Favorite

Lipid Nanoparticles and their Application in Nanomedicine

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 8, 2016-07 ,pp. : 662-672

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-based Nanoparticles for Nucleic Acid Delivery

By Li Weijun Szoka Francis

Pharmaceutical Research, Vol. 24, Iss. 3, 2007-03 ,pp. : 438-449

Springer Publishing Company

Access to resources Recommend Favorite

Platform for Lipid Based Nanocarriers' Formulation Components and their Potential Effects: A Literature Review

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6613-6629

Bentham Science Publishers

Access to resources Recommend Favorite

Polysaccharide-Based Nanoparticles: A Versatile Platform for Drug Delivery and Biomedical Imaging

Current Medicinal Chemistry, Vol. 19, Iss. 19, 2012-07 ,pp. : 3212-3229

Bentham Science Publishers

Access to resources Recommend Favorite